CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+10.99%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$10.6B
AUM Growth
+$1.15B
(+12%)
Cap. Flow
+$331M
Cap. Flow
% of AUM
3.12%
Top 10 Holdings %
Top 10 Hldgs %
22.38%
Holding
858
New
50
Increased
272
Reduced
342
Closed
45
Top Buys
| 1 |
Amgen
AMGN
|
$99.4M |
| 2 |
Merck
MRK
|
$74.3M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$52.7M |
| 4 |
Thermo Fisher Scientific
TMO
|
$36.6M |
| 5 |
Danaher
DHR
|
$36.3M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$86.9M |
| 2 |
Apple
AAPL
|
$60.7M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$31.9M |
| 4 |
Kimberly-Clark
KMB
|
$28.1M |
| 5 |
Arista Networks
ANET
|
$21.4M |
Sector Composition
| 1 | Healthcare | 35.9% |
| 2 | Technology | 20.42% |
| 3 | Consumer Discretionary | 9.53% |
| 4 | Communication Services | 7.72% |
| 5 | Financials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
GE Aerospace
GE
$296B
| $3.99M | 0.04% |
128,487
-3,170
| -2% | -$98.4K |
|
377
Baxter International
BAX
$12.5B
| $3.99M | 0.04% |
49,559
-1,755
| -3% | -$141K |
|
378
Exelon
EXC
$43.9B
| $3.98M | 0.04% |
155,856
-944
| -0.6% | -$24.1K |
|
|
NBL
379
DELISTED
Noble Energy, Inc.
NBL
| $3.94M | 0.04% |
+460,929
| New | +$3.94M |
|
|
NUAN
380
DELISTED
Nuance Communications, Inc.
NUAN
| $3.92M | 0.04% |
118,000
-39,000
| -25% | -$1.29M |
|
381
International Paper
IP
$25.7B
| $3.86M | 0.04% |
100,664
+26,492
| +36% | +$1.02M |
|
382
Autoliv
ALV
$9.63B
| $3.78M | 0.04% |
51,860
+46,500
| +868% | +$3.39M |
|
383
CME Group
CME
$94.4B
| $3.75M | 0.04% |
22,430
-1,640
| -7% | -$274K |
|
384
Copart
CPRT
$47B
| $3.73M | 0.04% |
126,780
+14,584
| +13% | +$429K |
|
385
Regions Financial
RF
$24.1B
| $3.71M | 0.03% |
321,420
+4,826
| +2% | +$55.6K |
|
386
Zoom
ZM
$25B
| $3.71M | 0.03% |
+7,883
| New | +$3.71M |
|
387
DaVita
DVA
$9.86B
| $3.69M | 0.03% |
43,101
+1,403
| +3% | +$120K |
|
388
T-Mobile US
TMUS
$284B
| $3.69M | 0.03% |
32,228
+4,000
| +14% | +$457K |
|
389
ConocoPhillips
COP
$116B
| $3.66M | 0.03% |
111,575
-3,935
| -3% | -$129K |
|
390
Corning
GLW
$61B
| $3.66M | 0.03% |
112,870
+52,182
| +86% | +$1.69M |
|
|
NGM
391
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $3.64M | 0.03% |
228,764
| – | – |
|
392
Tandem Diabetes Care
TNDM
$850M
| $3.63M | 0.03% |
32,000
-3,000
| -9% | -$341K |
|
393
Microchip Technology
MCHP
$35.6B
| $3.62M | 0.03% |
70,374
-52,526
| -43% | -$2.7M |
|
394
Esperion Therapeutics
ESPR
$540M
| $3.57M | 0.03% |
95,955
-20,849
| -18% | -$775K |
|
395
Avantor
AVTR
$9.07B
| $3.55M | 0.03% |
157,963
-13,037
| -8% | -$293K |
|
|
RDUS
396
DELISTED
Radius Health, Inc.
RDUS
| $3.54M | 0.03% |
312,025
| – | – |
|
397
Marvell Technology
MRVL
$54.6B
| $3.54M | 0.03% |
89,050
-2,876
| -3% | -$114K |
|
398
Altria Group
MO
$112B
| – | – |
-8,700
| Closed | -$341K |
|
399
Sangamo Therapeutics
SGMO
$165M
| $3.5M | 0.03% |
370,000
| – | – |
|
400
US Bancorp
USB
$75.9B
| $3.45M | 0.03% |
96,286
-6,313
| -6% | -$226K |
|